The University of North Carolina at Chapel Hill
| UNC-CH
| UNC-Chapel Hill
  • UNC Calendar
  • Libraries
  • Maps
  • UNC Departments
  • Search UNC
  • Accessibility
Innovate Carolina Logo
  • Service Areas
    • Innovation Strategy & Impact
    • Design Thinking and Innovation Recharge Consulting Services
    • Design and Innovation for the Public Good
    • Institute for Convergent Science
    • Impact Measurement and Reporting
    • Investor Programs
    • Startup Accelerators and Venture Services
    • Strategic Partnerships
    • Student Innovation Services
    • Office of Technology Commercialization
      • Inventors
      • Industry
      • Impact
      • About Us
      • Company Profiles
  • Startups
  • Impact
  • Tech-to-Market
  • About
    • What Is Innovate Carolina?
    • Team
    • Vision, Mission & Values
    • Strategy
    • Reports
    • Give
    • Opportunities
  • Events
  • Econ Dev
  • Stories
    • Top News
    • Newsletter

Category: IP & Commercialization

« Previous 1 2
kickstart-awards-spring-2019-header
  • IP & Commercialization,
  • Startups & Ventures

Hope for cystic fibrosis patients

Story by WRAL TechWire Path BioAnalytics (PBA), a precision medicine startup with ties to UNC Chapel Hill, has scored the...
path-bioanalytics
  • IP & Commercialization,
  • Startups & Ventures

Path BioAnalytics announces new license for targeted CF therapy

Read full announcement on Path BioAnalytics site Path BioAnalytics Inc. (PBA), a precision medicine company focused on the discovery and...
810_3622 copy
  • IP & Commercialization,
  • Startups & Ventures

Turning the tables on unhealthy products

UNC public health venture Counter Tools gives communities and policy makers insights to reduce the impact of tobacco and other...
kim-brouwer-lab
  • IP & Commercialization

UNC Inventor of the Year: Kim Brouwer

By Gary Moss, University Gazette Twenty years ago, Kim L. R. Brouwer was a young clinician scientist in Carolina’s School...
bacteria-163711_1280
  • IP & Commercialization,
  • Startups & Ventures

Aiming to be a pioneer in the biopharmaceuticals field

Ward Peterson joined Symberix in late 2013 after realizing that the company had potential to make unprecedented strides in the...
blood-cells
  • IP & Commercialization,
  • Startups & Ventures

Ensuring patient safety

Clinical Sensors, a development-stage biotechnology company based in Research Triangle Park, is developing sensors that can detect and diagnose life-threatening...
Screen Shot 2019-05-03 at 3.33.30 PM
  • IP & Commercialization,
  • Startups & Ventures

Go with your gut

By Jacquelyn Melinek NC Business News Wire Altis Biosystems, a biotechnology company based in Chapel Hill, North Carolina, has developed...
Pinnacle Hill Logo Full Color
  • IP & Commercialization,
  • Startups & Ventures

Pinnacle Hill appoints Jon L. Collins as chief scientific officer

Jon Collins will lead the company’s innovative drug discovery and development initiatives. Jon L. Collins, a seasoned research and development...
908
  • IP & Commercialization

Handheld hazard detection

Over the past few years, 908 Devices has quietly advanced from a startup to a nearly 100-employee company – making...
shallow-waters-post
  • Innovation & Entrepreneurship,
  • Economic & Social Impact,
  • IP & Commercialization,
  • Startups & Ventures

Video: Tapping Into Coast Innovations

inspiring-next-generation-women-startups-labs
  • Innovation & Entrepreneurship,
  • Economic & Social Impact,
  • IP & Commercialization,
  • Startups & Ventures

Inspiring the next generation of women innovators

Ryan dualogics
  • Innovation & Entrepreneurship,
  • IP & Commercialization,
  • Startups & Ventures

A new class of protein-based therapies

zika-mosquito
  • IP & Commercialization

UNC-Chapel Hill researchers file patent for Zika virus vaccine

By Mackenzie Harris Four researchers at UNC-Chapel Hill filed an application with the U.S. Patent and Trademark Office for a...
computer-3343887_1280
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Vast Therapeutics Lands $15M Series A Funding, CF Foundation Funding

Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507)...
kickstart-lab
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Applications open for KickStart Commercialization Awards

Request for Applications: KickStart Venture Services Commercialization Awards Application Deadline: January 31, 2019 at 5 p.m. Download Request for Applications...
wet-lab-1
  • Funding & Investors,
  • IP & Commercialization

$65 Million Pinnacle Hill fund opens for RFPs

New funding opportunity: Translational research and drug development Pinnacle Hill, UNC-Chapel Hill’s new partnership with Deerfield Management, offers you an...
byers_tom1
  • Innovation & Entrepreneurship,
  • IP & Commercialization,
  • Startups & Ventures

Podcast: The Collision of Ethics and Entrepreneurship

With Tom Byers, professor of entrepreneurship at Stanford University Data privacy concerns at Facebook. Fraud at Theranos. Sexual harassment controversies...
ribometrix-carolina-lin-natalie-mcdonald-2
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Ribometrix wraps up $30M funding round

Ribometrix, a three-year-old startup focused on the use of ribonucleic acid, a nucleic acid present in all cells known as RNA,...
indie-do-good-tile-2
  • Innovation & Entrepreneurship,
  • IP & Commercialization,
  • Startups & Ventures

Podcast: Passion-Driven Entrepreneurship and Making

With Ben Barras, president and chief operating officer at Indie Do Good Find what you love and do it. When...
test-tubes
  • IP & Commercialization

UNC, Deerfield Management partnership to accelerate drug discovery

UNC-Chapel Hill and Deerfield Management announce the creation of Pinnacle Hill to accelerate the discovery of new medicines Deerfield Management...
podcast-christina-jackson-dental
  • Innovation & Entrepreneurship,
  • IP & Commercialization,
  • Startups & Ventures

Podcast: In Perfect Alignment

Dental Researcher Creates Braces of the Future with 3D Printing Getting braces for straighter teeth is a rite of passage...
ai-drug-discovery-molecule
  • IP & Commercialization

AI technology teaches itself to design new drugs faster

By Eshelman School of Pharmacy An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School...
OTC-name-change
  • Innovation & Entrepreneurship,
  • IP & Commercialization

Announcement: New Name for Commercialization Office (formerly OCED/OTD)

To: Campus Faculty, Students and Staff From: Judith Cone, Vice Chancellor for Innovation, Entrepreneurship and Economic Development I am pleased...
Schoenfisch-UNC-Inventor-of-Year-Presentation
  • Innovation & Entrepreneurship,
  • IP & Commercialization

Inventor of the Year: Mark Schoenfisch makes NO the optimistic answer

Mark Schoenfisch likes to quip that his favorite letters are “N” and “O.” That might seem like a surprising preference...
kickstart-lab
  • Funding & Investors,
  • IP & Commercialization,
  • Startups & Ventures

Two UNC-affiliated startups win KickStart awards, pursue novel therapies for cystic fibrosis, blood clots

More effective therapies for cystic fibrosis and blood clots could be on their way, thanks in part to a recent...
« Previous 1 2
Innovate Carolina Logo
  • Find us on Linkedin
  • Find us on Facebook
  • Follow us on Instagram
  • Subscribe to our YouTube Channel
136 E. Rosemary Street, Suite 100, Chapel Hill, NC 27514 | 919-966-3929
© 2026 The University of North Carolina at Chapel Hill

GDPR Cookie Banner

This website uses cookies and similar technologies to understand visitor experiences. By using this website, you consent to UNC-Chapel Hill's cookie usage in accordance with their Privacy Notice.

Innovate Carolina
Powered by  GDPR Cookie Compliance (opens in a new tab)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.